Literature DB >> 17657420

Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer.

M Bellomi1, S Rizzo, L L Travaini, L Bazzi, G Trifirò, M G Zampino, D Radice, G Paganelli.   

Abstract

PURPOSE: The aim of this study was to compare the diagnostic value of multidetector computed tomography (MDCT) and F18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) for the detection of local and distant recurrence in patients operated on for rectal cancer.
MATERIALS AND METHODS: Sixty-seven patients who underwent radical surgery for rectal cancer and were followed up with FDG-PET/CT and MDCT were included in this retrospective study. The FDG-PET/CT and MDCT findings were independently compared with histological sampling or 2 years' follow-up.
RESULTS: Local recurrence occurred in 15/67 patients. MDCT diagnosed local recurrence in 15/15 cases and FDG-PET/CT in 14/15. Sensitivity and specificity were 100% and 98% for MDCT and 93% and 98% for FDG-PET/CT, respectively. Hepatic lesions were found in 17/67 patients. All hepatic metastases were detected by both techniques. Pulmonary metastases occurred in 8/67 patients: they were correctly identified in all cases by MDCT and in 6/8 by FDG-PET/CT.
CONCLUSIONS: MDCT and FDG-PET/CT showed high sensitivity and specificity for the detection of local recurrence of rectal cancer. Both techniques were equally accurate for the detection of hepatic metastases. MDCT showed slightly higher sensitivity and positive predictive value in detecting pulmonary metastases compared with FDG-PET/CT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657420     DOI: 10.1007/s11547-007-0172-2

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  24 in total

1.  Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.

Authors:  Thomas Beyer; Gerald Antoch; Andreas Bockisch; Joerg Stattaus
Journal:  J Nucl Med       Date:  2005-03       Impact factor: 10.057

2.  Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases.

Authors:  S Zink; G Kayser; H J Gabius; K Kayser
Journal:  Eur J Cardiothorac Surg       Date:  2001-06       Impact factor: 4.191

3.  Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?

Authors:  T Denecke; B Rau; K-T Hoffmann; B Hildebrandt; J Ruf; M Gutberlet; M Hünerbein; R Felix; P Wust; H Amthauer
Journal:  Eur Radiol       Date:  2005-04-02       Impact factor: 5.315

4.  PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.

Authors:  A K Berthelsen; S Holm; A Loft; T L Klausen; F Andersen; L Højgaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05-21       Impact factor: 9.236

5.  Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer.

Authors:  P Flamen; S Stroobants; E Van Cutsem; P Dupont; G Bormans; N De Vadder; F Penninckx; L Van Hoe; L Mortelmans
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

6.  Surgery for pulmonary metastases from colorectal carcinoma.

Authors:  M Inoue; Y Kotake; K Nakagawa; K Fujiwara; K Fukuhara; T Yasumitsu
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

7.  A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.

Authors:  Harvey G Moore; Tim Akhurst; Steven M Larson; Bruce D Minsky; Madhu Mazumdar; Jose G Guillem
Journal:  J Am Coll Surg       Date:  2003-07       Impact factor: 6.113

8.  Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer.

Authors:  Andrew G Renehan; Sarah T O'Dwyer; David K Whynes
Journal:  BMJ       Date:  2004-01-10

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 10.  Follow-up of patients with curatively resected colorectal cancer: a practice guideline.

Authors:  Alvaro Figueredo; R Bryan Rumble; Jean Maroun; Craig C Earle; Bernard Cummings; Robin McLeod; Lisa Zuraw; Caroline Zwaal
Journal:  BMC Cancer       Date:  2003-10-06       Impact factor: 4.430

View more
  10 in total

1.  Do DWI and quantitative DCE perfusion MR have a prognostic value in high-grade serous ovarian cancer?

Authors:  Francesca De Piano; Valentina Buscarino; Dulia Maresca; Patrick Maisonneuve; Giovanni Aletti; Roberta Lazzari; Andrea Vavassori; Massimo Bellomi; Stefania Rizzo
Journal:  Radiol Med       Date:  2019-08-31       Impact factor: 3.469

2.  Contrast-enhanced MRI and PET-CT in the evaluation of patients with suspected local recurrence of rectal carcinoma.

Authors:  F Fiocchi; V Iotti; G Ligabue; A Pecchi; G Luppi; B Bagni; F Rivasi; P Torricelli
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

Review 3.  [Modern CT and PET/CT imaging of the liver].

Authors:  J Klasen; T A Heusner; C Riegger; D Reichelt; J Kuhlemann; G Antoch; D Blondin
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

4.  The current role of PET-CT in the characterization of hepatobiliary malignancies.

Authors:  Ginseppe Garcea; Seok Ling Ong; Guy J Maddern
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

5.  Body composition assessment: comparison of quantitative values between magnetic resonance imaging and computed tomography.

Authors:  Chiara Zaffina; Rolf Wyttenbach; Alberto Pagnamenta; Rosario Francesco Grasso; Matteo Biroli; Filippo Del Grande; Stefania Rizzo
Journal:  Quant Imaging Med Surg       Date:  2022-02

6.  Computed Tomography-Based Body Composition in Patients With Ovarian Cancer: Association With Chemotoxicity and Prognosis.

Authors:  Maria Del Grande; Stefania Rizzo; Gabriele Maria Nicolino; Ilaria Colombo; Lorenzo Rossi; Lucia Manganaro; Filippo Del Grande
Journal:  Front Oncol       Date:  2021-11-16       Impact factor: 6.244

7.  CT-Derived Body Composition Values and Complications After Pneumonectomy in Lung Cancer Patients: Time for a Sex-Related Analysis?

Authors:  Stefania Rizzo; Francesco Petrella; Claudia Bardoni; Lorenzo Bramati; Andrea Cara; Shehab Mohamed; Davide Radice; Giorgio Raia; Filippo Del Grande; Lorenzo Spaggiari
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 6.244

8.  Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review.

Authors:  Stefania Rizzo; Isabel Scala; Angela Rodriguez Robayo; Marco Cefalì; Sara De Dosso; Stefano Cappio; Genti Xhepa; Filippo Del Grande
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

Review 9.  Radiologic Imaging Modalities for Colorectal Cancer.

Authors:  Wen Liu; An-Rong Zeng; Han-Zhou Tang; Jin-Wei Qiang
Journal:  Dig Dis Sci       Date:  2021-07-30       Impact factor: 3.487

Review 10.  [¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography imaging in oncology: initial staging and evaluation of cancer therapy.

Authors:  Ernest K J Pauwels; Annette W Coumou; Magdalena Kostkiewicz; Kalevi Kairemo
Journal:  Med Princ Pract       Date:  2013-01-26       Impact factor: 1.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.